Market OverviewThe Global Downstream Processing Market is expected to witness substantial growth over the next decade. Starting from a valuation of USD 36.1 billion in 2023, the market is projected to reach approximately USD 153.8 billion by 2033, reflecting a robust Compound Annual Growth Rate (CAGR) of 15.6% durin.
DBS Asian Insights Conference: Election s Over, What s the Government s Strategy to Grow the Economy and Achieve Golden Indonesia 2045? | Bahasa Indonesia.21 May 2024.0 min.
According to Market.us, the Antibody Production Market Size is anticipated to experience considerable growth, reaching an estimated value of around USD 62.2 billion by the year 2033. This represents a substantial increase from its valuation of USD 18.4 billion in 2023. Over the forecast period from 2024 to 2033, a s.
In the fast-paced domain of pharmaceutical contract development and manufacturing organizations (CDMOs), Selkirk Pharma believes it stands out as a beacon of innovation and reliability.
Increase in prevalence of chronic diseases, rise in research and development activities, and increase in government initiatives and funding are the major factors which drive the growth of the global antibody production market.Wilmington, New Castle, Delaware , April 08, 2024 (GLOBE NEWSWIRE) Allied Market Research published a report, titled, "Antibody Production Market by Product (Instruments, Consumables), Process (Upstream Processing, Downstream Processing), and End User (Pharmaceutical and